Unknown

Dataset Information

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?


ABSTRACT: Glioblastoma multiforme (GB) is the most aggressive and frequent primary malignant tumor in the central nervous system (CNS), with unsatisfactory and challenging treatment nowadays. Current standard of care includes surgical resection followed by chemotherapy and radiotherapy. However, these treatments do not much improve the overall survival of GB patients, which is still below two years (the 5-year survival rate is below 7%). Despite various approaches having been followed to increase the release of anticancer drugs into the brain, few of them demonstrated a significant success, as the blood brain barrier (BBB) still restricts its uptake, thus limiting the therapeutic options. Therefore, enormous efforts are being devoted to the development of novel nanomedicines with the ability to cros

SUBMITTER: Ruiz-Molina D 

PROVIDER: S-EPMC9563739 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature